Personal tools

Coexpression cluster:C2157: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2157_Mallassezderived_Smooth_Alveolar_Bronchial_Keratocytes_Tracheal_mesothelioma |id=C2157 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C2157_Mallassezderived_Smooth_Alveolar_Bronchial_Keratocytes_Tracheal_mesothelioma
|full_id=C2157_Mallassezderived_Smooth_Alveolar_Bronchial_Keratocytes_Tracheal_mesothelioma
|gostat_on_coexpression_clusters=GO:0031967!organelle envelope!0.0286527553894789!63875;10204$GO:0031975!envelope!0.0286527553894789!63875;10204$GO:0006228!UTP biosynthetic process!0.0286527553894789!654364$GO:0046051!UTP metabolic process!0.0286527553894789!654364$GO:0004550!nucleoside diphosphate kinase activity!0.0286527553894789!654364$GO:0046036!CTP metabolic process!0.0286527553894789!654364$GO:0009209!pyrimidine ribonucleoside triphosphate biosynthetic process!0.0286527553894789!654364$GO:0009208!pyrimidine ribonucleoside triphosphate metabolic process!0.0286527553894789!654364$GO:0006241!CTP biosynthetic process!0.0286527553894789!654364$GO:0006183!GTP biosynthetic process!0.0286527553894789!654364$GO:0046039!GTP metabolic process!0.0286527553894789!654364$GO:0009220!pyrimidine ribonucleotide biosynthetic process!0.0286527553894789!654364$GO:0009218!pyrimidine ribonucleotide metabolic process!0.0286527553894789!654364$GO:0009147!pyrimidine nucleoside triphosphate metabolic process!0.032089061554363!654364$GO:0006221!pyrimidine nucleotide biosynthetic process!0.032089061554363!654364$GO:0031090!organelle membrane!0.0353004691211007!63875;10204$GO:0006220!pyrimidine nucleotide metabolic process!0.0353004691211007!654364$GO:0016776!phosphotransferase activity, phosphate group as acceptor!0.0353004691211007!654364$GO:0005643!nuclear pore!0.0393385481596267!10204$GO:0019205!nucleobase, nucleoside, nucleotide kinase activity!0.0393385481596267!654364$GO:0046930!pore complex!0.0393385481596267!10204$GO:0044249!cellular biosynthetic process!0.0393385481596267!63875;654364$GO:0044453!nuclear membrane part!0.0393385481596267!10204$GO:0009206!purine ribonucleoside triphosphate biosynthetic process!0.0393385481596267!654364$GO:0009145!purine nucleoside triphosphate biosynthetic process!0.0393385481596267!654364$GO:0009201!ribonucleoside triphosphate biosynthetic process!0.0393385481596267!654364$GO:0009142!nucleoside triphosphate biosynthetic process!0.0393385481596267!654364$GO:0009205!purine ribonucleoside triphosphate metabolic process!0.0393385481596267!654364$GO:0009144!purine nucleoside triphosphate metabolic process!0.0393385481596267!654364$GO:0009199!ribonucleoside triphosphate metabolic process!0.0393385481596267!654364$GO:0009152!purine ribonucleotide biosynthetic process!0.0393385481596267!654364$GO:0009141!nucleoside triphosphate metabolic process!0.0393385481596267!654364$GO:0031965!nuclear membrane!0.0393385481596267!10204$GO:0009150!purine ribonucleotide metabolic process!0.0393385481596267!654364$GO:0009260!ribonucleotide biosynthetic process!0.0393385481596267!654364$GO:0006164!purine nucleotide biosynthetic process!0.0393385481596267!654364$GO:0006163!purine nucleotide metabolic process!0.0393385481596267!654364$GO:0009259!ribonucleotide metabolic process!0.0393385481596267!654364$GO:0009058!biosynthetic process!0.0393385481596267!63875;654364$GO:0005635!nuclear envelope!0.0438641156314734!10204
|id=C2157
|id=C2157
}}
}}

Revision as of 17:36, 18 May 2012


Full id: C2157_Mallassezderived_Smooth_Alveolar_Bronchial_Keratocytes_Tracheal_mesothelioma



Phase1 CAGE Peaks

Hg19::chr11:6704513..6704578,-p1@MRPL17
Hg19::chr12:120720030..120720046,+p1@NME2P1
Hg19::chr16:67880820..67880844,+p1@NUTF2
Hg19::chr17:49243792..49243828,+p2@NME1-NME2
p2@NME2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0031967organelle envelope0.0286527553894789
GO:0031975envelope0.0286527553894789
GO:0006228UTP biosynthetic process0.0286527553894789
GO:0046051UTP metabolic process0.0286527553894789
GO:0004550nucleoside diphosphate kinase activity0.0286527553894789
GO:0046036CTP metabolic process0.0286527553894789
GO:0009209pyrimidine ribonucleoside triphosphate biosynthetic process0.0286527553894789
GO:0009208pyrimidine ribonucleoside triphosphate metabolic process0.0286527553894789
GO:0006241CTP biosynthetic process0.0286527553894789
GO:0006183GTP biosynthetic process0.0286527553894789
GO:0046039GTP metabolic process0.0286527553894789
GO:0009220pyrimidine ribonucleotide biosynthetic process0.0286527553894789
GO:0009218pyrimidine ribonucleotide metabolic process0.0286527553894789
GO:0009147pyrimidine nucleoside triphosphate metabolic process0.032089061554363
GO:0006221pyrimidine nucleotide biosynthetic process0.032089061554363
GO:0031090organelle membrane0.0353004691211007
GO:0006220pyrimidine nucleotide metabolic process0.0353004691211007
GO:0016776phosphotransferase activity, phosphate group as acceptor0.0353004691211007
GO:0005643nuclear pore0.0393385481596267
GO:0019205nucleobase, nucleoside, nucleotide kinase activity0.0393385481596267
GO:0046930pore complex0.0393385481596267
GO:0044249cellular biosynthetic process0.0393385481596267
GO:0044453nuclear membrane part0.0393385481596267
GO:0009206purine ribonucleoside triphosphate biosynthetic process0.0393385481596267
GO:0009145purine nucleoside triphosphate biosynthetic process0.0393385481596267
GO:0009201ribonucleoside triphosphate biosynthetic process0.0393385481596267
GO:0009142nucleoside triphosphate biosynthetic process0.0393385481596267
GO:0009205purine ribonucleoside triphosphate metabolic process0.0393385481596267
GO:0009144purine nucleoside triphosphate metabolic process0.0393385481596267
GO:0009199ribonucleoside triphosphate metabolic process0.0393385481596267
GO:0009152purine ribonucleotide biosynthetic process0.0393385481596267
GO:0009141nucleoside triphosphate metabolic process0.0393385481596267
GO:0031965nuclear membrane0.0393385481596267
GO:0009150purine ribonucleotide metabolic process0.0393385481596267
GO:0009260ribonucleotide biosynthetic process0.0393385481596267
GO:0006164purine nucleotide biosynthetic process0.0393385481596267
GO:0006163purine nucleotide metabolic process0.0393385481596267
GO:0009259ribonucleotide metabolic process0.0393385481596267
GO:0009058biosynthetic process0.0393385481596267
GO:0005635nuclear envelope0.0438641156314734



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.